Growing from common ground: nontuberculous mycobacteria and bronchiectasis.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 19 03 2024
accepted: 28 05 2024
medline: 4 7 2024
pubmed: 4 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

Bronchiectasis and nontuberculous mycobacteria (NTM) are intricately intertwined, with NTM capable of being both a cause and consequence of bronchiectatic disease. This narrative review focuses on the common ground of bronchiectasis and NTM pulmonary disease (NTM-PD) in terms of diagnostic approach, underlying risk factors and treatment strategies. NTM-PD diagnosis relies on a combination of clinical, radiological and microbiological criteria. Although their epidemiology is complicated by detection and reporting biases, the prevalence and pathogenicity of NTM species vary geographically, with

Identifiants

pubmed: 38960614
pii: 33/173/240058
doi: 10.1183/16000617.0058-2024
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright ©The authors 2024.

Déclaration de conflit d'intérêts

Conflict of interest: E. Van Braeckel is principal investigator for clinical trials sponsored by Insmed, Boehringer Ingelheim, Vertex, and F2G. Her institution received fees for consultancy and/or lectures by Insmed and Vertex. She is the chair of Belgian Respiratory Society working group on respiratory infections. C. Bosteels has no disclosures to declare.

Auteurs

Eva Van Braeckel (E)

Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium Eva.vanbraeckel@ugent.be.
Respiratory Infection and Defense Lab (RIDL), Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
European Reference Network on rare respiratory diseases (ERN-LUNG).

Cédric Bosteels (C)

Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Respiratory Infection and Defense Lab (RIDL), Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
European Reference Network on rare respiratory diseases (ERN-LUNG).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH